Rheumatoid arthritis is primarily treated with conventional drugs like methotrexate. TNF inhibitors are effective but not for all. Patients with inadequate responses have options, including switching to different biologics like rituximab and abatacept. This evidence concerns the gene TNF and rheumatoid arthritis.